Brief: Austar Lifesciences expects loss attributable to increase for six months ending 30 June
13/06/2017 12:20
June 13 (Reuters) - Austar Lifesciences Ltd 6118.HK :
* Group is expected to record a substantial increase in loss
attributable to shareholders of co for six months ending 30 June
2017
* Expected result due to increase in budgeted costs mainly
due to prolonged execution time for certain projects
Source text for Eikon: ID:nHKS2wTPx6
Further company coverage: 6118.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Austar Lifesciences
See all newsAustar Lifesciences H1 profit drops on higher R&D spending
Brief: Austar Lifesciences Expects HY Profit Attributable Of RMB8 Million-RMB10 Million
Brief: Austar Lifesciences Posts FY Revenue RMB 1,530.7 Million
Brief: Austar Lifesciences Expects Profit Attributable Of Not Less Than RMB30 Million For FY
Brief: Austar Lifesciences Says Chen Yuewu Resigned As Executive Director